In last trading session, Legend Biotech Corp ADR (NASDAQ:LEGN) saw 1.23 million shares changing hands with its beta currently measuring 0.15. Company’s recent per share price level of $33.48 trading at $0.05 or 0.15% at ring of the bell on the day assigns it a market valuation of $6.16B. That closing price of LEGN’s stock is at a discount of -81.81% from its 52-week high price of $60.87 and is indicating a premium of 18.34% from its 52-week low price of $27.34. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.88 million shares which gives us an average trading volume of 1.79 million if we extend that period to 3-months.
For Legend Biotech Corp ADR (LEGN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.19. Splitting up the data highlights that, out of 11 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Legend Biotech Corp ADR (NASDAQ:LEGN) trade information
Upright in the green during last session for gaining 0.15%, in the last five days LEGN remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $33.48 price level, adding 4.53% to its value on the day. Legend Biotech Corp ADR’s shares saw a change of -22.30% in year-to-date performance and have moved -4.04% in past 5-day. Legend Biotech Corp ADR (NASDAQ:LEGN) showed a performance of 16.41% in past 30-days. Number of shares sold short was 14.37 million shares which calculate 6.39 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 75 to the stock, which implies a rise of 55.36% to its current value. Analysts have been projecting 75 as a low price target for the stock while placing it at a high target of 75. It follows that stock’s current price would drop -124.01% in reaching the projected high whereas dropping to the targeted low would mean a loss of -124.01% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0.79% during past 5 years.
Legend Biotech Corp ADR (NASDAQ:LEGN)’s Major holders
Insiders are in possession of 1.33% of company’s total shares while institution are holding 47.77 percent of that, with stock having share float percentage of 48.42%. Investors also watch the number of corporate investors in a company very closely, which is 47.77% institutions for Legend Biotech Corp ADR that are currently holding shares of the company. FMR LLC is the top institutional holder at LEGN for having 17.62 million shares of worth $780.46 million. And as of 2024-06-30, it was holding 9.6503 of the company’s outstanding shares.
The second largest institutional holder is PRICE T ROWE ASSOCIATES INC /MD/, which was holding about 11.49 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.292 of outstanding shares, having a total worth of $508.86 million.
